| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.20▼ | 3.20▼ | 3.20▼ | 3.22▲ | 3.11▲ |
| MA10 | 3.09▲ | 3.09▲ | 3.09▲ | 3.14▲ | 3.30▼ |
| MA20 | 3.10▲ | 3.10▲ | 3.10▲ | 3.03▲ | 3.21▲ |
| MA50 | 3.15▲ | 3.20▼ | 3.20▼ | 3.21▲ | 3.93▼ |
| MA100 | 3.59▼ | 3.74▼ | 3.76▼ | 3.25▲ | 4.66▼ |
| MA200 | 4.06▼ | 4.08▼ | 4.16▼ | 3.85▼ | 6.27▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | 0.021▲ | 0.021▲ | 0.047▲ | 0.048▲ |
| RSI | 51.231▲ | 50.677▲ | 50.673▲ | 54.744▲ | 46.993▼ |
| STOCH | 47.232 | 47.232 | 47.232 | 78.805 | 36.646 |
| WILL %R | -67.391 | -67.391 | -67.391 | -22.535▲ | -52.090 |
| CCI | -1.944 | -1.944 | -1.944 | 94.597 | 33.426 |
|
Tuesday, October 28, 2025 02:26 PM
Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosisNew Iqirvo® ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/10/25 | 3.25 | 3.25 | 3.25 | 3.25 | 0 |
| 27/10/25 | 3.24 | 3.25 | 3.24 | 3.25 | 700 |
| 24/10/25 | 3.41 | 3.41 | 3.05 | 3.25 | 4,100 |
| 23/10/25 | 3.05 | 3.31 | 3.05 | 3.31 | 500 |
| 22/10/25 | 2.99 | 3.02 | 2.99 | 3.02 | 300 |
| 21/10/25 | 3.27 | 3.27 | 2.96 | 3.20 | 6,700 |
| 20/10/25 | 3.15 | 3.23 | 2.89 | 3.23 | 4,600 |
| 17/10/25 | 2.77 | 3.16 | 2.77 | 3.16 | 9,100 |
| 16/10/25 | 2.76 | 2.95 | 2.76 | 2.95 | 700 |
| 15/10/25 | 2.82 | 2.85 | 2.74 | 2.74 | 1,300 |
|
|
||||
|
|
||||
|
|